Cite

    Invernizzi, R. et al. (2015). Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study. Lancet. 2 (11), pp. e465-e473. [Online].